Anastrozole Extends Breast Cancer Protection Once Stopped
A 5-year regimen of anastrozole protects women against new breast cancers for at least another 5 years they stop taking the drug. Medscape Medical News …read more
What can you do to reduce fibroid pain?
Uterine fibroids can be painful and disrupt daily life. Learn about what treatments and medications are available and how to ease the pain. …read more
Male scientists more likely to present findings positively
Clinical articles with male first or last authors tend to be more positive about findings than those with female first and last authors, says a new study. …read more
Omit Surgery in Early-Stage Breast Cancer? Not Yet
It’s an enticing idea in an age of breast cancer treatment de-escalation: omit surgery if a patient achieves what looks like a complete response to neoadjuvant chemotherapy. Medscape Medical News …read more
Weight gain during period: What to know
Some people may experience perceived or actual weight gain around the time of their period. Read on to find out why and how to prevent weight gain during a period. …read more
EMA Panel Backs Adalimumab Biosimilar Amsparity
The CHMP has recommended approval of Pfizer’s adalimumab biosimilar (Amsparity) for treatment of certain inflammatory and autoimmune disorders in adults and children. International Approvals …read more
Outcomes in TN Breast Cancer Predicted by Blood Biomarkers
Biomarkers of residual disease at surgery identify which triple-negative breast cancer patients already treated with neoadjuvant therapy will do well and which will do poorly over the next 2 years. Medscape Medical News …read more
New birth control pill provides contraception for a month
In pigs, researchers have developed a single birth control pill effective for 1 month. The pill could, one day, have a global impact on human health. …read more
Paclitaxel Now a Pill, but Needs 9 Hours of Fasting to Take
Among women with metastatic breast cancer, use of an investigational oral form of paclitaxel yielded a higher overall response rate than the IV form, but administration was unique and time-consuming. Medscape Medical News …read more
‘Remarkable’ New Data on Menopausal Hormone Therapy
Estrogen alone and estrogen/progestin have opposite effects on breast cancer risk; adding progestin may lead to a lifetime of increased risk. Medscape Medical News …read more